Center for Cancer and Hematologic Disease — Cherry Hill, New Jersey

Center for Cancer and Hematologic Disease is a clinical research site located in Cherry Hill, New Jersey, United States 08003.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Center for Cancer and Hematologic Disease has participated in 5 clinical trials.

Therapeutic areas: Lymphoma, Non-Hodgkin's, Non-Small Cell Lung Cancer, Carcinoma.

Sponsors: Celgene, Novartis Pharmaceuticals, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Cancer and Hematologic Disease?

Center for Cancer and Hematologic Disease has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Cancer and Hematologic Disease conducted?

Center for Cancer and Hematologic Disease has 5 clinical trials on record. Their work covers Lymphoma, Non-Hodgkin's, Non-Small Cell Lung Cancer, Carcinoma.

Is Center for Cancer and Hematologic Disease accredited by Crixeo Health?

Yes — Center for Cancer and Hematologic Disease holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Center for Cancer and Hematologic Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.